Women's health in menopause with a focus on hypertension

Netherlands Heart Journal

Volumn 17, Issue 2, 2009, Pages 68-72

  Maas, A H E M ^a   Franke, H R ^b  

^a ISALA HOSPITAL   (Netherlands)

^b MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

Cardiovascular risk; Hormones; Hypertension; Menopause; Prevention

Indexed keywords

ANGIOTENSIN II ANTAGONIST; ANTIDEPRESSANT AGENT; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DROSPIRENONE; ESTRADIOL; ESTROGEN; GESTAGEN;

CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MENOPAUSAL SYNDROME; PRESCRIPTION; REVIEW; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; WOMEN'S HEALTH;

EID: 70349210417     PISSN: 15685888     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03086220     Document Type: Review

References (56)

1. Hulley S, Grady D, Bush T, Furberg C, Herrington DM, Riggs B, et al. The Heart and Estrogen/progestin Replacement Study (HERS) research group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998; 280:605-613
2. Herrington DM, Reboussin DM, Brosnihan KB, Sharp PC, Shumaker SA, Snyder TE, et al. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med 2000;343:522-529 (Pubitemid 30650747)
3. Writing group for the Women's Health Initiative investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results of the Women's Health Initiative controlled trial. JAMA 2002;288:321-333
4. The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701-1712
5. Collins P, Rosano G, Casey C, Daly C, Gambacciani M, Hadji P, et al. Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists. Eur Heart J 2007;28:2028-2040 (Pubitemid 47579557)
6. Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease. The Framingham Study. Ann Intern Med 1978;89:157-161 (Pubitemid 8395464)
7. Bairey Merz CM, Johnson BD, Sharaf BL, Bittner V, Berga SL, Braunstein GD, et al. Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study. J Am Coll Cardiol 2003;41:413-419 (Pubitemid 36164495)
8. Sutton-Tyrell K, Lassila HC, Meilahn E, Bunker C, Metthews KA, Kuller LH. Carotid atherosclerosis in premenopausal and postmenopausal women and its association with risk factors measured after menopause. Stroke 1998;29:1116-1121 (Pubitemid 28265464)
9. Christian RC, Harrington S, Edwards WD, Oberg AL, Fitzpatrick LA. Estrogen status correlates with the calcium content of coronary atherosclerotic plaques in women. J Clin Endocrinol Metab 2002;87:1062-1067 (Pubitemid 36121066)
10. Post WS, Goldschmidt-Clermont PJ, Wilhide CC, Heldman AW, Sussman MS, Ouyang P, et al. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res 1999;43:985-991 (Pubitemid 29413198)
11. Clarkson TB. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression. Menopause 2007;14:373-384
12. Ouyang P, Michos ED, Karas RH. Hormone replacement therapy and the cardiovascular system. J Am Coll Cardiol 2006;47:1741-1753
13. Vickers MR, MacLennan AH, Lawton B, Ford D, Martin J, Meredith SK, et al. Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomized controlled trial of hormone replacement therapy in postmenopausal women. BMJ 2007;335:239-250 (Pubitemid 47262422)
14. Pasternak RC, Abrams J, Greenland P, Smaha LA, Wilson PWF, Houston-Miller N. Task force #1- Identification of coronary heart disease risk: is there a detection gap? J Am Coll Cardiol 2003;41:1863-1874
15. Mikkola TS, Clarkson TB, Notelovitz M. Postmenopausal hormone therapy before and after the women's health initiative study: what consequences? Ann Med 2004;36:402-413 (Pubitemid 39334842)
16. Rossouw JE, Prentice RL, Manson JE, Wu LL, Barad D, Barnabei VM, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297:1465-1477 (Pubitemid 46556472)
17. Manson JE, Allison MA, Rossouw JE, Carr JJ, Langer RD, Hsia J, et al. Estrogen therapy and coronary-artery calcification. N Engl J Med 2007;356:2591-2602
18. Vitale C, Mercuro G, Cerquetani E, Marazzi G, Patrizi R, Pellicia F et al. Time since menopause influences the acute and chronic effect of estrogens on endothelial function. Arterioscler Throm Vasc Biol 2008;28:348-352 (Pubitemid 351161210)
19. Freedman RR, Norton D, Woodward S, Cornelissen G. Core body temperature and circadian rythm of hot flashes in menopausal women. J Clin Endocrinol Metab 1995;80:2354-2358
20. Nelson HG. Menopause. Lancet 2008;371:760-770
21. Staropoli CA, Flaws JA, Bush TL, Moulton AW. Predictors of menopausal hot flashes. J Womens Health 1998;7:1149-1155
22. Gold EB, Sternfeld B, Kelsey JL, Brown C, Mouton C, Reame N, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol 2000;152:463-473 (Pubitemid 30696368)
23. Thurston RC, Sowers MR, Sutton-Tyrrell K, Everson-Rose SA, Lewis TT, Edmundowicz D, et al. Abdominal adiposity and hot flashes among midlife women. Menopause 2008;15:429-434 (Pubitemid 351656746)
24. Gerber LM, Sievert LL, Warren K, Pickering TG, Schwartz JE. Hot flashes are associated with increased ambulatory blood pressure. Menopause 2007;14:308-315 (Pubitemid 46673483)
25. James GD, Sievert LL, Flanagan E. Ambulatory blood pressure and heart rate in relation to hot flash experience among women of menopausal age. Ann Human Biol 2004;31:49-58. (Pubitemid 38131690)
26. Ikeda H, Inoue T, Uemura S, Kaibara R, Tanaka H, Node K. Effects of candesartan for middle-aged and elderly women with hypertension and menopausal-like symptoms. Hypertens Res 2006;29:1007-1012 (Pubitemid 46206587)
27. Freedman RR. Biochemical, metabolic and vascular mechanisms in menopausal hot flashes. Fertil Steril 1998;70:332-337
28. Wenger NK. Coronary heart disease: an older women's major health risk. BMJ 1997; 5:1085-1090 (Pubitemid 27458407)
29. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;25:305-313
30. Wassertheil-Smoller S, Anderson G, Psaty BM, Black HR, Manson JE, Wong N, et al. Hypertension and its treatment in postmenopausal women. Baseline data from the Women's Health Initiative. Hypertension 2000;36:780-789 (Pubitemid 30943734)
31. Fletcher AE, Bulpitt CJ, Tuomilehto J et al., on behalf of the Syst-Eur Trial investigators. Quality of life in elderly patients with isolated systolic hypertension: baseline data from the Syst-Eur Trial. J Hypertens 1998;16:1117-1124
32. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007;335:974-985 (Pubitemid 350144670)
33. Conen D, Ridker PM, Buring JE, Glynn RJ. Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study. BMJ 2007;335:432-440 (Pubitemid 47372649)
34. Conen D, Ridker PM, Mora S, Buring JE, Glynn RJ. Blood pressure and risk of developing type 2 diabetes mellitus: The Women's Health Study. Eur Heart J 2007;28:2937-2943 (Pubitemid 350233022)
35. Gierach GL, Johnson BD, Bairey Merz CN, Kelsey SF, Bittner V, Olson MB, et al. Hypertension, Menopause, and coronary artery disease risk in the Women's Ischemia Syndrome Evaluation (WISE) Study. J Am Coll Cardiol 2006;47:50S-58S. (Pubitemid 43170831)
36. Oparil S. Women and hypertension. What did we learn from the Women's Health Initiative? Cardiol Rev 2006;14:267-275 (Pubitemid 44624585)
37. Staessen JA, van der Heijden-Spek JJ, Safar ME, Den Hond E, Gasowski J, Fagard RH, et al. Menopause and the characteristics of the large arteries in a population study. J Hum Hypertens 2001;15:511-518 (Pubitemid 32780641)
38. Coylewright M, Reckelhoff JF, Ouyang P. Menopause and hypertension. An age-old debate. Hypertension 2008;51:952-959
39. Khalil RA. Sex hormones as potential modulators of vascular function in hypertension. Hypertension 2005;46:249-254
40. Reckelhoff JF. Gender differences in the regulation of blood pressure. Hypertension 2001;37:1199-1208 (Pubitemid 34163570)
41. Ashraf MS, Vongpatanasin W. Estrogen and hypertension. Curr Hypertens Reports 2006;8:368-376
42. Reckelhoff JF, Fortepiani LA. Novel mechanisms responsible for postmenopausal hypertension. Hypertension 2004;43:918-923
43. Schunkert H, Danser AH, Hense H-W, Derkx FH, Kurzinger S, Riegger GA. Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation 1997;95:39-45. (Pubitemid 27029940)
44. Pechère-Bertschi A, Burnier M. Female sex hormones, salt, and blood pressure regulation. Am J Hypertens 2004;17:994-1001. (Pubitemid 39361675)
45. Narkiewicz K, Philips BG, Kato M, Hering D, Bieniaszewski L, Somers VK. Gender-selective interaction between aging, blood pressure and sympathetic nerve activity. Hypertension 2005;45: 522-525 (Pubitemid 40411253)
46. Rappelli A. Hypertension and obesity after the menopause. J Hypertens 2002;20:S26-S28.
47. Carr MC. The emerge of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003;88:2404-2411
48. Lloyd-Jones DM, Leip EP, Larson MG, D'Agostino RB, Beiser A, Wilson PWF, et al.Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 2006;113:791-798 (Pubitemid 43754299)
49. Mosca L, Banka CL, Benjamin EJ, Berra K, Bushnell C, Dolor RJ, et al. Evidence- based guidelines for cardiovascular disease prevention in women: 2007 update. J Am Coll Cardiol 2007;49:1230-1250 (Pubitemid 46400344)
50. Guidelines Committee. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J 2007;28:2375-2414 www.escardio.org/admin/GuidelinesReferences/guidelines-CVD- prevention-ES.pdf
51. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE-project. Eur Heart J 2003;24:987-1003. (Pubitemid 36712275)
52. Grady D. Management of menopausal symptoms. N Engl J Med 2006;355:2338-2347
53. Board of trustees of the North American Menopause Society (NAMS). Estrogen and progestogen use in postmenopausal women: July 2008 position statement of the North American Menopause Society. Menopause 2008;15:584-603.
54. Roberts H. Managing the Menopause. BMJ 2007;334:736-741
55. White WB, Hanes V, Chauhan V, Pitt B. Effects of a new hormone therapy, drospirenone and 17β-oestradiol in postmenopausal women with hypertension. Hypertension 2006;48:246-253 (Pubitemid 44309819)
56. Preston RA, Norris PM, Alonso AB, Ni P, Hanes V, Larara AH. Randomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide. Menopause 2007;14:408-414